Eric Wayne Golightly

Array ( [id] => 4971260 [patent_doc_number] => 20070111262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-17 [patent_title] => 'Method to assay test substances' [patent_app_type] => utility [patent_app_number] => 11/272050 [patent_app_country] => US [patent_app_date] => 2005-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6493 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20070111262.pdf [firstpage_image] =>[orig_patent_app_number] => 11272050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5479608 [patent_doc_number] => 20090202565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'TORC POLYNUCLEOTIDES AND POLYPEPTIDES AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 11/577961 [patent_app_country] => US [patent_app_date] => 2005-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 40540 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202565.pdf [firstpage_image] =>[orig_patent_app_number] => 11577961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6247015 [patent_doc_number] => 20100136524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'TARGET PROTEIN AND TARGET GENE IN DRUG DESIGNING AND SCREENING METHOD' [patent_app_type] => utility [patent_app_number] => 11/577350 [patent_app_country] => US [patent_app_date] => 2005-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27538 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136524.pdf [firstpage_image] =>[orig_patent_app_number] => 11577350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5619404 [patent_doc_number] => 20060188937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'G-protein estrogen membrane receptor' [patent_app_type] => utility [patent_app_number] => 11/252084 [patent_app_country] => US [patent_app_date] => 2005-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13627 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188937.pdf [firstpage_image] =>[orig_patent_app_number] => 11252084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5843153 [patent_doc_number] => 20060121499 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Methods of identifying glucocorticoids without the detrimental side effects of bone loss' [patent_app_type] => utility [patent_app_number] => 11/236042 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11261 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121499.pdf [firstpage_image] =>[orig_patent_app_number] => 11236042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 159033 [patent_doc_number] => 07674596 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-03-09 [patent_title] => 'Transfected cell line and a method using the same for the high throughput screening for inhibitors of the T-type calcium channel alpha-1H' [patent_app_type] => utility [patent_app_number] => 11/162487 [patent_app_country] => US [patent_app_date] => 2005-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5873 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/674/07674596.pdf [firstpage_image] =>[orig_patent_app_number] => 11162487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016647 [patent_doc_number] => 20070259856 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Method for Activating Trpv4 Channel Receptors by Agonists' [patent_app_type] => utility [patent_app_number] => 11/574749 [patent_app_country] => US [patent_app_date] => 2005-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21519 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259856.pdf [firstpage_image] =>[orig_patent_app_number] => 11574749 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5815096 [patent_doc_number] => 20060084704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Methods and compositions for enhancing degradation of nuclear receptor transcription factors and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/218889 [patent_app_country] => US [patent_app_date] => 2005-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 13984 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084704.pdf [firstpage_image] =>[orig_patent_app_number] => 11218889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5602294 [patent_doc_number] => 20060292639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Splice variant of the vanilloid receptor VR1A' [patent_app_type] => utility [patent_app_number] => 11/201937 [patent_app_country] => US [patent_app_date] => 2005-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15571 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292639.pdf [firstpage_image] =>[orig_patent_app_number] => 11201937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703877 [patent_doc_number] => 08828939 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Modified vitamin K dependent polypeptides' [patent_app_type] => utility [patent_app_number] => 11/632552 [patent_app_country] => US [patent_app_date] => 2005-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11011 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11632552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792653 [patent_doc_number] => 20080293627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Thyrotropin Receptor Preparations, Binding Regions Thereof, Antibody and Hormone Interactions Therewith, and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/573676 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39793 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293627.pdf [firstpage_image] =>[orig_patent_app_number] => 11573676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5360990 [patent_doc_number] => 20090035784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-05 [patent_title] => 'NPC1L1 AND NPC1L1 INHIBITORS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/572227 [patent_app_country] => US [patent_app_date] => 2005-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 37269 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20090035784.pdf [firstpage_image] =>[orig_patent_app_number] => 11572227 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 679432 [patent_doc_number] => 07083935 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-01 [patent_title] => 'Androgen receptor complex-associated protein' [patent_app_type] => utility [patent_app_number] => 11/189521 [patent_app_country] => US [patent_app_date] => 2005-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12260 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/083/07083935.pdf [firstpage_image] =>[orig_patent_app_number] => 11189521 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480030 [patent_doc_number] => 20090202987 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Canis sphingosine 1-phosphate receptor isoform 2' [patent_app_type] => utility [patent_app_number] => 11/658375 [patent_app_country] => US [patent_app_date] => 2005-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18722 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202987.pdf [firstpage_image] =>[orig_patent_app_number] => 11658375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5747861 [patent_doc_number] => 20060110792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Potassium channels, nucleotide sequences encoding them, and methods of using same' [patent_app_type] => utility [patent_app_number] => 11/178538 [patent_app_country] => US [patent_app_date] => 2005-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15798 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20060110792.pdf [firstpage_image] =>[orig_patent_app_number] => 11178538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726879 [patent_doc_number] => 20060057639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'CaMKII/calcium channel phosphorylation-related compositions and methods' [patent_app_type] => utility [patent_app_number] => 11/155266 [patent_app_country] => US [patent_app_date] => 2005-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16806 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057639.pdf [firstpage_image] =>[orig_patent_app_number] => 11155266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5608451 [patent_doc_number] => 20060269967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Novel diagnosis & treatment tools for cancer using the NRIP antibody and RNA interference' [patent_app_type] => utility [patent_app_number] => 11/138335 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11230 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20060269967.pdf [firstpage_image] =>[orig_patent_app_number] => 11138335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5016170 [patent_doc_number] => 20070259379 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'REGULATION OF GLUCOSE AND INSULIN LEVELS BY GNT-4 GLYCOSYLTRANSFERASE ACTIVITY' [patent_app_type] => utility [patent_app_number] => 11/569655 [patent_app_country] => US [patent_app_date] => 2005-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 20063 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20070259379.pdf [firstpage_image] =>[orig_patent_app_number] => 11569655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019375 [patent_doc_number] => 20050221394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Ion channel' [patent_app_type] => utility [patent_app_number] => 11/136464 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 18719 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221394.pdf [firstpage_image] =>[orig_patent_app_number] => 11136464 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019418 [patent_doc_number] => 20050221437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/136623 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 56 [patent_figures_cnt] => 56 [patent_no_of_words] => 23286 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221437.pdf [firstpage_image] =>[orig_patent_app_number] => 11136623 [rel_patent_id] =>[rel_patent_doc_number] =>)